Monday - Friday - 7:30am - 6:00pm   /   Lunes - Viernes - 7:30am - 6:00pm

Phase I Unit

Our 30-bed phase I unit is the only one in the Caribbean and one of the few in South America. Our phase I unit has state-of-the-art monitoring technology that includes remote telemetry and sophisticated software designed to manage phase I trials.

Fundación de Investigación has conducted trials with confinement duration of up to 16 days, including multiple intensive pharmacokinetic and pharmacodynamic trials as SAD and MAD for many molecules. We also conduct hepatic impairment and drug-to-drug interaction studies. We have a database of normal volunteers and the capability to conduct all kinds of early studies in both normal volunteers and patients. Our phase I unit’s experienced staff and facilities allow the trials to be conducted without interruption 7 days a week.

 

Who We Are?

Located in San Juan, Puerto Rico, Fundación de Investigación (FDI) is a clinical research center with state-of-the-art facilities that comprise medical treatment for multiple conditions, a 30-bed phase I unit, an in-house bioanalytical laboratory, multispecialty experienced personnel, and the latest in medical technology. We are also an active medical care facility for patients with diverse medical ailments.

Executive Leadership

Dr. Jose F. Rodriguez-Orengo
Chief Executive Offcicer - CEO,
Chief Scientific Officer & BioLab Director


Grisell Ortíz-Lasanta, MD
Associate Director

Mirelis Acosta, MD
Chief Medical Officer

Michelle Echeandia
Chief Operating Officer

Our partners

Gilead Pharmaceuticals
Amgen
Astra Zeneca
Bristol Myers Squibb
GlaxoSmithKline
Merck Sharp
Novartis Pharmaceuticals
Pfizer
Sanofi-aventis
Jansen Pharmaceuticals

Where to find us?

Address
Fundación de Investigación
998 Muñoz Rivera Ave.
San Juan, PR 00927

Phone Number
Tel. (787) 722-1248
Fax. (787) 721-6098